(Reuters) – An experimental monoclonal antibody developed at the U.S. National Institutes of Health (NIH) prevented malaria for up to nine months in volunteers exposed to the disease-causing parasite in a small trial, researchers reported on Wednesday in the New…
Read More
Coronavirus breakthrough: Scientists trial experimental drug that targets blood clots
The British Heart Foundation is working on a trial to further explore the assumption that the clots are cause by a hormone imbalance brought on by Covid-19. The drug will be one of several to be tested for their use against…
Read More